Event Review: Opportunities and Challenges of AI in Healthcare Sector – the 58th Open Day Event of Guangdong Medical Valley
On the afternoon of August 8th, a workshop on “Opportunities and Challenges of AI in Healthcare Sector” for the 58th Open Day event of Guangdong Medical Valley (GDMV) was held in the International Roadshow Hall on the 7th floor of Guangzhou Bank Building.
The guests included: Mr. Li Feng, deputy director of Guangzhou International Investment Promotion Center, Mr. Lu Yao, founder and Chairman of the Board of Pvmed (Perception Vision) , Mr. Xu Xudong, director of Yongtianda Private Equity in Hong Kong, Mr. Lv Haiyan, CEO and co-founder of MINDSGO Technologies Co., Ltd, Mr. Jonathan Hakim, founder of Healthcare Drinks (HCD) , Mr. Wu Xiaohang, ophthalmologist of Zhongshan Ophthalmic Center, Sun Yat-sen University, Mr. Yang Haozhen, Chief Medical Counselor of Tencent Healthcare Business Department, Ms. Xu Juan, CTO of Medical Image of AliHealth, Mr. Chen Haosi, deputy director of Yuexiu Industrial Fund, Mr. Guo Yujie, General Manager of Comprehensive Health Investment Department of Yuexiu Industrial Fund, Mr. Zhang Jinglei, vice president of Business and Marketing of Airdoc, Mr. Li Jiaqi, Managing Director of Guangzhou Quanjiafu Technologies Co., Ltd, and Mr. Xie Jiasheng, CEO of Guangdong Medical Valley.
Mr. Jonathan Hakim, founder of Healthcare Drinks (HCD), introduced HCD to us: Healthcare Drinks, dedicated to the development of healthcare industry in China and elsewhere, provides a platform for the leading healthcare executives to exchange ideas and meet more people, creating a professional space for learning and communicating.
Afterwards, Mr. Li Feng, deputy director of Guangzhou International Investment Promotion Center, introduced to us: Guangzhou International Investment Promotion Center is the only non-profit professional institute under the Guangzhou municipal government to promote investment. The city has abundant medical resources and very preferential policies, so investment fund for biomedical was set up to attract more foreign healthcare enterprises to do business in Guangzhou. Currently, a modern industrial system has been formed basically, and its focuses in the future would be in the following five : new generation of information technology, artificial intelligence, biomedical (IAB) and new energy & materials (NEM).
Mr. Jason Xie, CEO of GDMV, expressed sincere gratitude to all the guests come from afar. He also introduced about GDMV: The GDMV Nansha Business Park was located in Nansha district of Guangzhou. Nansha is the business hub of Guangdong-Hong Kong-Macao Greater Bay Area, as well as one of the model bases for healthy tourism, and is therefore of great strategic importance, not to mention the policies it boasts for industry development. In recent years, AI technology has become more and more popular and mature in the medical industry, and has been applied to many fields from retinal screening to brain, epilepsy, etc. with technology expanding from image recognition to motion recognition.
The GDMV Business Park now has already implemented some programs of Comprehensive Health industry, such as programs in medical devices, gene, antibody, precision medicine and so on. Meanwhile, the International Healthcare Industry Innovation Center was also set up in Nansha, dedicated to the establishment of a platform that can enable communication and information sharing.
Then there came the roadshows of enterprises. Mr. Li Jiaqi, Managing Director of Guangzhou Quanjiafu Technologies Co., Ltd introduced to us the intelligent smelling diagnosis program. This “smelling diagnosis” pioneered in applying AI technology to smell instead of vision, having received many approvals from international medical community.
The topic of the first round table discussion: Imaging diagnosis of AI.
The first round table discussion was hosted by Mr. Guo Yujie, General Manager of Comprehensive Health Investment Department of Yuexiu Industrial Fund. And the keynote speakers are: Mr. Yang Haozhen, Chief Medical Counselor of Tencent Healthcare Business Department, Mr. Lv Haiyan, CEO and co-founder of MINDSGO Technologies Co., Ltd, Mr. Wu Xiaohang, ophthalmologist of Zhongshan Ophthalmic Center, Sun Yat-sen University, and Mr. Zhang Jinglei, vice president of Business and Marketing of Airdoc. The topic was “Imaging diagnosis of AI”.
The topic of the second round table discussion: How to apply AI to healthcare sector.
The second round table discussion was hosted by Mr. Chen Haosi, deputy director of Yuexiu Industrial Fund. And the keynote speakers are: Ms. Xu Juan, CTO of Medical Image of AliHealth, Mr. Lu Yao, founder and Chairman of the Board of Pvmed (Perception Vision), and Mr. Xu Xudong, director of Yongtianda Private Equity in Hong Kong.
As the platform of exchange in Comprehensive Health Industry, GDMV has held 58 Open Day events, mobilizing over 10,000 people offline and over 100,000 people online. It has also successfully helped many entrepreneurship programs to gain access to financing. The GDMV Open Day event will be held monthly, so be sure to stay tuned!
GF Xinde's bcc International Life Sciences Fund: IPO project accounted for 12% of the total U.S. biotech IPO in the first half of 2018
Since its establishment in less than two years, the Bay City Capital International Life Sciences Fund (established by GF Xinde) has successfully achieved four IPOs in Nasdaq. Now the fifth project is in the process of IPO. Let us look forward to the foreseeable future.
Besides, more than 80% of the projects invested by the BCC International Life Sciences Fund of GF Xinde are in compliance with the listing rules of the Hong Kong Stock Exchange for biotech companies. In addition, the Hong Kong Stock Exchange provides more opportunities for the development of life sciences companies. The HK Stock Exchange has recently undergone significant changes, creating more chances for life sciences enterprises (including our funded ocmpanies) to start IPO in Hong Kong.
Following the great trend of the development of life sciences industry, GF Xinde's investment strategy "Global Resource & Chinese Power" has been accepted and recognized by the world life sciences industry.
The 2018 Hengqin Scientific and Technological Entrepreneurship Competition Awaits Competitors, Winners Can Get R&D Funding up to 100 Million Yuan